NewsRamp Health & Wellness Podcast

Dr. Kixx Goldman questions the impact of labeling in therapy, while attorney Willard Bakeman challenges America's justice system in two new books.

HeartBeam progresses post-FDA clearance, Sigyn Therapeutics explores merger options, gut microbiota's role in cancer treatment, Aditxt's acquisition in oncology, and LIXTE Biotechnology expands cancer trial partnerships.

Tonix Pharmaceuticals launches TONMYA for fibromyalgia, HeartBeam advances ECG technology, while Creative Biolabs pioneers non-vaccine mRNA therapeutics and lipid-based drug delivery systems.

Aclarion CEO to discuss AI platform for identifying chronic back pain. Investors can meet for 1-on-1 sessions. For more info, visit Aclarion's newsroom.

GeoVax Labs introduces GEO-CM04S1 for immunocompromised patients, NeOnc Technologies enhances brain cancer treatment, Liv Women partners with Ashunta Sheriff Beauty for holistic self-care, and Friendly Recovery Center offers resources on Antisocial Personality Disorder therapies.

Learn about financial results from leading MedTech companies, new healthcare strategies, breakthroughs in brain tumor research, and the benefits of physical activity on health.

GeoVax Labs explores vaccine procurement, BioCorRx strengthens patent portfolio, NeuroThera Labs patents novel weight loss therapy, Sono-Tek receives medical equipment order, and more medical advancements and recognitions are highlighted.

Oragenics Inc. starts Phase IIa trial in Australia for ONP-002 neurosteroid targeting concussion treatment. HeartBeam partners with Mount Sinai to boost AI-ECG algorithm development for personalized cardiac insights.

Tonix Pharmaceuticals presents TONMYA data, Soligenix's SGX945 receives designation, AirTrap's new spore trap, SS Innovations reports growth, BioVaxys and Adiverna collaborate on mRNA vaccines, and more updates in healthcare and dental care.

HeartBeam, LIXTE Biotechnology, SPARC Health, Soligenix Inc., Calidi Biotherapeutics, and NRx Pharmaceuticals are advancing healthcare through conferences, partnerships, milestones, and innovative therapies.